A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer.
about
Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studiesCervical cancer prevention and treatment research in Africa: a systematic review from a public health perspectiveCost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach.Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education.Ethical considerations of universal vaccination against human papilloma virusSignificantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDRKnowledge about Cervical Cancer and Associated Factors among 15-49 Year Old Women in Dessie Town, Northeast Ethiopia.Resources Required for Cervical Cancer Prevention in Low- and Middle-Income CountriesComparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation.Determinants of Cervical Cancer Screening Uptake among Women in Ilorin, North Central Nigeria: A Community-Based StudyCervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.Cervical cancer screening and treatment in Uganda.Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India.An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia.Vaginal self-sampling as a diagnosis tool in low-income countries and potential applications for exploring the infectious causes of miscarriage.Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.Uptake of Cervical Cancer Screening and Associated Factors Among 15-49-Year-Old Women in Dessie Town, Northeast Ethiopia.Costs of integrating cervical cancer screening at an HIV clinic in Kenya.Risk assessment to guide cervical screening strategies in a large Chinese population.Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India.Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting.Opportunistic cervical cancer screening of women visitors at a trade fair in India.Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan.Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries.Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.Cervical Cancer Screening in the United States-Affiliated Pacific Islands: Options and Opportunities.Acceptability of cervical cancer screening using visual inspection among women attending a childhood immunization clinic in Uganda.Cervical cytology and human papillomavirus among asymptomatic healthy volunteers in Vientiane, Lao PDR.Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala.
P2860
Q28083434-41EDCEFF-F69E-4C33-B572-B69793D6B568Q28601706-E2F1D1B7-E2D4-4F6F-B4C1-86CA93F554A5Q30235262-0F7C9C9F-D276-4E28-8950-FCC27FE1FBD5Q30388952-6371E7F0-81CB-40AE-A743-C2DEE760100DQ33771876-E57EF7F4-7509-417B-8614-CDEB53C39C7FQ34434281-F84E5FCD-AFE6-4995-8204-E69E34C64748Q35141381-28FEF9F3-13C5-4C59-A193-5D3FC5E8C813Q36092294-C47F796F-4EF3-499D-A6B1-7A3DD5DEA458Q36134178-DD449068-3ADB-4BFC-B571-C29170283701Q36149942-01D7D696-79B7-4FF7-9160-F6774ED9DDC6Q36154922-8506D6DF-3A10-4D8F-8853-D3A20DE344F7Q36184620-F3D493B8-D894-41B0-9E5A-95AA7A3C2E9FQ36531577-BF499271-333C-411C-BC8D-3F308375DA1DQ37011809-369A002C-7FC5-4C67-AEEF-34EF99DA7CB9Q37672588-BC71D67D-AEFA-420A-AF34-88CA322E80DDQ37679237-8F73E998-8AD8-4990-A956-2D120F9742F3Q37703131-9DA42AD3-32D7-48C5-986B-856F1B00E1F5Q38384071-0BF94EF1-A0A8-4CF6-87AB-65AB0CEA29B4Q38386055-25EF526E-FC16-45BE-AEB6-083F29B5ED9BQ38672124-CD55F110-73BC-49AF-8E80-941F953C6B77Q38679549-C73FB3C1-C61C-4FEB-9CB3-3309F177CB41Q38723374-AAA8B3C6-5D9A-4968-B9C4-635AC19E5101Q38739053-867E2B61-AEAB-4731-859E-2EAABC849E1CQ38850707-F1D359A5-0C19-414E-BE9C-A271E83CC88EQ38851920-03D9EE8F-D6E6-467A-A1C1-CF2CC6F8259DQ39853374-B70912C4-12DD-4079-A9F8-847D758A2BCBQ40367113-DEE7B9A1-845D-4D34-8C84-2BEBCDB4771BQ40821522-23E71B91-3B77-4205-A3A1-2D7CA2B9C31EQ41066018-7F70BFAD-C335-43E5-A6C6-CD66E10904DEQ41516378-C3400783-8CDC-4FC9-A4FD-D7EBA8180A1EQ41670583-12459F80-7B9D-482A-B51E-CA79AE57F143Q42184589-A4B2DC2C-0E7A-43B2-9526-EF143828163BQ42341977-0AEA5A7F-E4F1-45B8-A5AC-584C27A3B17DQ42700786-D26DD06E-54B5-4889-931C-E626C363E182Q43247407-0E3F9F42-ADB9-427E-834B-F2EA9FDE667FQ45074054-FDA6DD52-8DC9-4828-873B-E8B49AF7306BQ45167073-A3854ED1-59F3-4A4E-8207-3B8C722CE11CQ46919001-CA9F79B8-43BE-4863-B941-C3EBC52111B9Q47119314-C0107D88-72E9-4871-BFA8-3B12263BC3A0Q47150003-37B40A47-84EB-4F05-BE92-949877C42F2E
P2860
A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A multicountry evaluation of c ...... detection of cervical cancer.
@ast
A multicountry evaluation of c ...... detection of cervical cancer.
@en
type
label
A multicountry evaluation of c ...... detection of cervical cancer.
@ast
A multicountry evaluation of c ...... detection of cervical cancer.
@en
prefLabel
A multicountry evaluation of c ...... detection of cervical cancer.
@ast
A multicountry evaluation of c ...... detection of cervical cancer.
@en
P2093
P2860
P1476
A multicountry evaluation of c ...... detection of cervical cancer.
@en
P2093
Florence Mirembe
Jeanette Lim
Josaphat Byamugisha
Jose Jeronimo
Juan Jose Amador
Labani Satyanarayana
Pooja Bansil
Proma Paul
Roger Peck
START-UP Study Group
P2860
P304
P356
10.1097/IGC.0000000000000084
P577
2014-03-01T00:00:00Z